| 4-HNE | 4-hydroxynonenal; |
| AA | arachidonic acid; |
| ACSL4 | Acyl-CoA synthetase long-chain family member 4; |
| AD | Alzheimer’s disease; |
| ALS | Amyotrophic lateral sclerosis; |
| BSO | L-buthionine-(S,R)-sulfoximine; |
| CNS | central nervous system; |
| DFO | Deferoxamine mesylate; |
| DMF | dimethyl fumarate; |
| FPN | ferroportin; |
| FRDA | Friedreich’s ataxia; |
| FT | ferritin; |
| FTL | ferritin light chain; |
| FSP1 | ferroptosis suppressor protein 1; |
| FTMt | mitochondrial ferritin; |
| FXN | frataxin; |
| GPX | glutathione peroxidase; |
| GSH | glutathione; |
| HCC | hepatocellular carcinoma cells; |
| Hmox1 | Heme Oxygenase 1; |
| HSPB1 | heat shock beta-1 protein; |
| IRE | iron response element; |
| IREB2 | RNA-binding protein 2; |
| IRP | iron-responsive element-binding protein; |
| ISC | iron-sulfur clusters; |
| LIP | labile iron pool; |
| LOOH | lipid peroxides; |
| MDA | malondialdehyde; |
| NAC | N-acetylcysteine; |
| NCOA4 | nuclear receptor coactivator 4; |
| NQO1 | quinone oxidoreductase; |
| NRF2 | Nuclear factor erythroid 2-related factor 2; |
| OMOV | Omaveloxolone; |
| PE | phosphatidylethanolamine; |
| PUFAs | Polyunsatured fatty acids; |
| ROS | reactive oxygen species; |
| SeC | Selenocysteine; |
| SFN | sulforaphane; |
| Steap3 | six-transmembrane epithelial antigen of the prostate 3; |
| TF | transferrin; |
| TFR1 | transferrin receptor complex; |
| UTRs | untranslated regions |